Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131434) titled 'Efficacy of 0.1% cyclosporine A cationic nanoemulsion in the treatment of perennial allergic conjunctivitis' on Sept. 2.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Tianjin Medical University Eye Hospital

Condition: perennial allergic conjunctivitis

Intervention: experimental group:0.1% CsA-CE eye drops were administered bilaterally, twice daily (BID), with one drop instilled in each eye per administration.

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-09-10

Target Sample Size: experimental group:33;the control group:33;

Countries of Recru...